We’ve got new information about Dexcom’s G7 launch and much more. CEO Kevin Sayer says it’ll be available in the US before the end of March. Sayer joins us from the J.P. Morgan Healthcare Conference in San Francisco. He talks about Dexcom’s pump partners, when the FDA will let them put in features they already…
Happy new year! What will 2023 bring for diabetes technology? We bring our best guesses to the table and we take a look back at what we said would happen last year. Stacey is joined by Chris Wilson on a Twitter Spaces Chat and you’ll also hear from Mike Hoskins for a look back to…
This week.. after a year of deliberations, the US FDA approves the newest product from Dexcom, the G7. This is a much smaller device, with all-in-one sensor and transmitter, shorter warm up time and many more new features. Stacey talks with Dexcom’s Chief Operating Officer Jake Leach. They do a lighting round of questions to…
Jeff Dachis founded One Drop in 2014, after his own type 1 diagnosis. Known for its sleek meter design and more recently for on-demand telehealth services, One Drop is moving into something new. Jeff shares how that includes what they’re calling a continuous health sensor. We’ll talk about what that term means, how it could…
Eversense is a CGM that goes under the skin and stays there for up to six months. The company that makes it has big plans to make that time period longer and to make the sensor even more accurate. Stacey talks to Senseonics Chief Medical Officer Dr. Francine Kaufman. They had a wide ranging conversation…
Type One Talks is a popular YouTube channel with videos that help manage all sort of technology and situations around diabetes. But its host and founder says he wasn’t always that interested a diabetes deep dive. It all changed with his first CGM. Tom was an accountant in his former life so he really does…
When it comes to using a CGM, the first question you may ask is, “How quickly can I get one?!” But this week, you’ll hear there are a few other questions you may want to ask in order to get the most out of continuous glucose monitoring. In this excerpt from “Still the World’s Worst…
We’re taking a look at the design decisions that go into diabetes technology, specifically Dexcom’s G7. Beyond the accuracy and interoperability we all want, they also look at things like dexterity, feel and hand strength. Alex Diener is Dexcom’s Senior Director of Global Product Design. He lives with type 1 and he shared a lot…
Dexcom’s G7 is still not approved in the United States, but it’s in limited release in Europe. This week, friend of the show Kamil Armacki, better known as Nerdabetic, interviews Dexcom’s Chief Operating Officer, Jake Leach. Find more about Kamil over at his amazing YouTube Channel here: https://www.youtube.com/c/nerdabetic This podcast is not intended as medical…
Researchers at UVA recently published a study called Design and Validation of an Open-Source Closed-Loop Testbed for Artificial Pancreas Systems. They say what they’ve set up here is quote – a valid tool that can be used by the research community to demonstrate the effectiveness of different control algorithms and safety features for APS, automated…